Filomena de Nigris1, Francesco Cacciatore2,3,4, Francesco P Mancini5, Dino F Vitale3, Gelsomina Mansueto6, Francesco P D'Armiento6, Concetta Schiano7, Andrea Soricelli7, Claudio Napoli7,8. 1. Department of Biochemistry, Biophysics and General Pathology, University of Campania Luigi Vanvitelli, Naples, Italy. 2. Department of Cardiac Surgery, Ospedale Monaldi, Naples, Italy. 3. Epidemiology Section, Maugeri Foundation, Telese Terme, Italy. 4. Department of Translational Medical Sciences, Federico II University of Naples, Naples, Italy. 5. Department of Sciences and Technologies, University of Sannio, Benevento, Italy. 6. Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy. 7. Institute of Diagnostic and Nuclear Research, Istituto di Ricovero e Cura a Carattere Scientifico, Naples, Italy. 8. Department of Medical, Surgical, Neurological, Aging and Metabolic Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
Abstract
Importance: Although increasingly strong evidence suggests a role of maternal total cholesterol and low-density lipoprotein cholesterol (LDLC) levels during pregnancy as a risk factor for atherosclerotic disease in the offspring, the underlying mechanisms need to be clarified for future clinical applications. Objective: To test whether epigenetic signatures characterize early fetal atherogenesis associated with maternal hypercholesterolemia and to provide a quantitative estimate of the contribution of maternal cholesterol level to fetal lesion size. Design, Setting, and Participants: This autopsy study analyzed 78 human fetal aorta autopsy samples from the Division of Human Pathology, Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy. Maternal levels of total cholesterol, LDLC, high-density lipoprotein cholesterol (HDLC), triglycerides, and glucose and body mass index (BMI) were determined during hospitalization owing to spontaneous fetal death. Data were collected and immediately processed and analyzed to prevent degradation from January 1, 2011, through November 30, 2016. Main Outcomes and Measurements: Results of DNA methylation and messenger RNA levels of the following genes involved in cholesterol metabolism were assessed: superoxide dismutase 2 (SOD2), low-density lipoprotein receptor (LDLR), sterol regulatory element binding protein 2 (SREBP2), liver X receptor α (LXRα), and adenosine triphosphate-binding cassette transporter 1 (ABCA1). Results: Among the 78 fetal samples included in the analysis (59% male; mean [SD] fetal age, 25 [3] weeks), maternal cholesterol level explained a significant proportion of the fetal aortic lesion variance in multivariate analysis (61%; P = .001) independently by the effect of levels of HDLC, triglycerides, and glucose and BMI. Moreover, maternal total cholesterol and LDLC levels were positively associated with methylation of SREBP2 in fetal aortas (Pearson correlation, 0.488 and 0.503, respectively), whereas in univariate analysis, they were inversely correlated with SREBP2 messenger RNA levels in fetal aortas (Pearson correlation, -0.534 and -0.671, respectively). Epivariations of genes controlling cholesterol metabolism in cholesterol-treated human aortic endothelial cells were also observed. Conclusions and Relevance: The present study provides a stringent quantitative estimate of the magnitude of the association of maternal cholesterol levels during pregnancy with fetal aortic lesions and reveals the epigenetic response of fetal aortic SREBP2 to maternal cholesterol level. The role of maternal cholesterol level during pregnancy and epigenetic signature in offspring in cardiovascular primary prevention warrants further long-term causal relationship studies.
Importance: Although increasingly strong evidence suggests a role of maternal total cholesterol and low-density lipoprotein cholesterol (LDLC) levels during pregnancy as a risk factor for atherosclerotic disease in the offspring, the underlying mechanisms need to be clarified for future clinical applications. Objective: To test whether epigenetic signatures characterize early fetal atherogenesis associated with maternal hypercholesterolemia and to provide a quantitative estimate of the contribution of maternal cholesterol level to fetal lesion size. Design, Setting, and Participants: This autopsy study analyzed 78 human fetal aorta autopsy samples from the Division of Human Pathology, Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy. Maternal levels of total cholesterol, LDLC, high-density lipoprotein cholesterol (HDLC), triglycerides, and glucose and body mass index (BMI) were determined during hospitalization owing to spontaneous fetal death. Data were collected and immediately processed and analyzed to prevent degradation from January 1, 2011, through November 30, 2016. Main Outcomes and Measurements: Results of DNA methylation and messenger RNA levels of the following genes involved in cholesterol metabolism were assessed: superoxide dismutase 2 (SOD2), low-density lipoprotein receptor (LDLR), sterol regulatory element binding protein 2 (SREBP2), liver X receptor α (LXRα), and adenosine triphosphate-binding cassette transporter 1 (ABCA1). Results: Among the 78 fetal samples included in the analysis (59% male; mean [SD] fetal age, 25 [3] weeks), maternal cholesterol level explained a significant proportion of the fetal aortic lesion variance in multivariate analysis (61%; P = .001) independently by the effect of levels of HDLC, triglycerides, and glucose and BMI. Moreover, maternal total cholesterol and LDLC levels were positively associated with methylation of SREBP2 in fetal aortas (Pearson correlation, 0.488 and 0.503, respectively), whereas in univariate analysis, they were inversely correlated with SREBP2 messenger RNA levels in fetal aortas (Pearson correlation, -0.534 and -0.671, respectively). Epivariations of genes controlling cholesterol metabolism in cholesterol-treated human aortic endothelial cells were also observed. Conclusions and Relevance: The present study provides a stringent quantitative estimate of the magnitude of the association of maternal cholesterol levels during pregnancy with fetal aortic lesions and reveals the epigenetic response of fetal aortic SREBP2 to maternal cholesterol level. The role of maternal cholesterol level during pregnancy and epigenetic signature in offspring in cardiovascular primary prevention warrants further long-term causal relationship studies.
Authors: Michael M Mendelson; Asya Lyass; Christopher J O'Donnell; Ralph B D'Agostino; Daniel Levy Journal: JAMA Cardiol Date: 2016-04-01 Impact factor: 14.676
Authors: F P D'Armiento; A Bianchi; F de Nigris; D M Capuzzi; M R D'Armiento; G Crimi; P Abete; W Palinski; M Condorelli; C Napoli Journal: Stroke Date: 2001-11 Impact factor: 7.914
Authors: C Napoli; F P D'Armiento; F P Mancini; A Postiglione; J L Witztum; G Palumbo; W Palinski Journal: J Clin Invest Date: 1997-12-01 Impact factor: 14.808
Authors: Linda Sommese; Alberto Zullo; Concetta Schiano; Francesco P Mancini; Claudio Napoli Journal: Stem Cell Rev Rep Date: 2017-04 Impact factor: 5.739
Authors: Fanneke E Alkemade; Adriana C Gittenberger-de Groot; Anja E Schiel; J Conny VanMunsteren; Bianca Hogers; Leontien S J van Vliet; Robert E Poelmann; Louis M Havekes; Ko Willems van Dijk; Marco C DeRuiter Journal: Arterioscler Thromb Vasc Biol Date: 2007-07-26 Impact factor: 8.311
Authors: Amanda M Perak; Nicola Lancki; Alan Kuang; Darwin R Labarthe; Norrina B Allen; Svati H Shah; Lynn P Lowe; William A Grobman; Jean M Lawrence; Donald M Lloyd-Jones; William L Lowe; Denise M Scholtens Journal: JAMA Date: 2021-02-16 Impact factor: 56.272
Authors: Mark E Pepin; Concetta Schiano; Marco Miceli; Giuditta Benincasa; Gelsomina Mansueto; Vincenzo Grimaldi; Andrea Soricelli; Adam R Wende; Claudio Napoli Journal: Exp Cell Res Date: 2021-01-27 Impact factor: 3.905